AxoGen, Inc. (AXGN) Set to Announce Quarterly Earnings on Wednesday
AxoGen, Inc. (NASDAQ:AXGN) will be announcing its earnings results after the market closes on Wednesday, August 2nd. Analysts expect the company to announce earnings of ($0.08) per share for the quarter.
AxoGen (NASDAQ:AXGN) last announced its earnings results on Thursday, May 4th. The medical equipment provider reported ($0.11) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.10) by $0.01. The company had revenue of $12.24 million during the quarter, compared to analyst estimates of $11.83 million. AxoGen had a negative return on equity of 155.78% and a negative net margin of 32.05%. On average, analysts expect AxoGen to post $-0.33 EPS for the current fiscal year and $-0.07 EPS for the next fiscal year.
AxoGen, Inc. (NASDAQ:AXGN) opened at 16.35 on Wednesday. AxoGen, Inc. has a 52 week low of $6.45 and a 52 week high of $17.25. The company has a 50-day moving average of $15.76 and a 200-day moving average of $12.43. The firm’s market capitalization is $541.10 million.
COPYRIGHT VIOLATION WARNING: “AxoGen, Inc. (AXGN) Set to Announce Quarterly Earnings on Wednesday” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/07/26/axogen-inc-axgn-set-to-announce-quarterly-earnings-on-wednesday.html.
AXGN has been the subject of a number of research reports. ValuEngine upgraded shares of AxoGen from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Cantor Fitzgerald initiated coverage on shares of AxoGen in a report on Thursday, June 29th. They issued an “overweight” rating and a $18.00 price target for the company. Finally, Wedbush restated an “outperform” rating and issued a $14.00 price target (down from $17.00) on shares of AxoGen in a report on Friday, May 19th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $14.38.
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.